Zetia Labeling Adds Myopathy/Rhabdomyolysis Precaution
This article was originally published in The Pink Sheet Daily
Executive Summary
Revised labeling for Merck's lipid-lowering therapy notes most cases of rhabdomyolysis occurred in patients who had been taking statins. The skeletal muscle precaution follows the recent addition of a precaution against use with cyclosporine.